Quick Answer
ROCKWELL MEDICAL, INC. reported Research And Development Expense of $0.00 for the year ending 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -100.0% in Research And Development Expense from 2024 to 2025.
- This data is from ROCKWELL MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $9.41 million | Q2 2012: $10.88 million | Q3 2012: $16.24 million | Q4 2012: $11.75 million | Q1 2013: $12.75 million | Q2 2013: $10.22 million | Q3 2013: $10.61 million | Q4 2013: $5.79 million | Q1 2014: $4.62 million | Q2 2014: $186.7 thousand | Q3 2014: $1.30 million | Q4 2014: $1.68 million | Q1 2015: $799.6 thousand | Q2 2015: $885.3 thousand | Q3 2015: $1.25 million | Q4 2015: $2.03 million | Q1 2016: $1.31 million | Q2 2016: $2.06 million | Q3 2016: $1.26 million | Q4 2016: $1.20 million | Q1 2017: $1.21 million | Q2 2017: $1.68 million | Q3 2017: $1.30 million | Q4 2017: $2.13 million | Q1 2018: $1.67 million | Q2 2018: $1.56 million | Q3 2018: $808.2 thousand | Q1 2019: $497.3 thousand | Q2 2019: $2.96 million | Q3 2019: $1.48 million | Q1 2020: $1.82 million | Q2 2020: $1.62 million | Q3 2020: $1.75 million | Q1 2021: $1.81 million | Q2 2021: $2.42 million | Q3 2021: $1.22 million | Q1 2022: $1.57 million | Q2 2022: $926.0 thousand | Q3 2022: $469.0 thousand | Q1 2023: $278.0 thousand | Q2 2023: $167.0 thousand | Q3 2023: $494.0 thousand | Q1 2024: $18.0 thousand | Q2 2024: $0.00 | Q3 2024: $0.00 | Q1 2025: $0.00 | Q2 2025: $0.00 | Q3 2025: $0.00.
- Over the full 13 years of available data (2009 to 2025), ROCKWELL MEDICAL, INC.'s Research And Development Expense has declined by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $19.0 thousand | Fiscal year 2023: $1.11 million | Fiscal year 2018: $5.64 million | Fiscal year 2017: $6.32 million | Fiscal year 2016: $5.84 million | Fiscal year 2015: $4.96 million | Fiscal year 2014: $7.78 million | Fiscal year 2013: $39.38 million | Fiscal year 2012: $48.27 million | Fiscal year 2011: $17.81 million | Fiscal year 2010: $3.42 million | Fiscal year 2009: $6.45 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: